IDEAYA Biosciences to Participate in Upcoming December 2023 Investor Relations Event

/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted...

Related Keywords

Yujiros Hata ,Andres Ruiz Briseno ,Peter Lawson ,Exchange Commission ,Nasdaq ,Biosciences Inc ,Equity Research Analyst ,Chief Executive Officer ,Managing Director ,Equity Research ,Quarterly Report ,Vice President ,Ideaya Biosciences ,Nc ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,Biotechnology ,Trade Show News ,